Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta-analysis.

Bao-Hong YuanRu-Hong LiRong-Rui HuoMin-Jun LiGeorgios Papatheodoridis Jian-Hong Zhong

Published in: Journal of gastroenterology and hepatology (2022)

Current evidence from a sizable population suggests that TDF is associated with significantly lower HCC risk compared with ETV treatment in patients who are from Asia and/or nucleos(t)ide naïve.

Keyphrases

systematic review
end stage renal disease
ejection fraction
newly diagnosed
hepatitis b virus
acute lymphoblastic leukemia
peritoneal dialysis
prognostic factors
randomized controlled trial
patient reported outcomes
antiretroviral therapy
patient reported